Lanying Du

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Protein Protein

Respiratory Syndrome Coronavirus

Inflammatory Response

Top Venues

Journal of virology

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Gang Wang, Abhishek K Verma, Juan Shi, Xiaoqing Guan, David K Meyerholz, Fan Bu, Wei Wen, Bin Liu, Fang Li, Stanley Perlman, Lanying Du
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV. NPJ vaccines 9 (1) (2024)
Gang Wang, Abhishek K Verma, Xiaoqing Guan, Fan Bu, Abby E Odle, Fang Li, Bin Liu, Stanley Perlman, Lanying Du
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge. Journal of virology (2024)
Gang Wang, Abhishek K Verma, Juan Shi, Xiaoqing Guan, David K Meyerholz, Fan Bu, Wei Wen, Bin Liu, Fang Li, Stanley Perlman, Lanying Du
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV. NPJ vaccines 9 (1) (2024)
Gang Wang, Abhishek K Verma, Juan Shi, Xiaoqing Guan, David K Meyerholz, Fan Bu, Wei Wen, Bin Liu, Fang Li, Stanley Perlman, Lanying Du
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV. NPJ vaccines 9 (1) (2024)
Gang Ye, Ruangang Pan, Fan Bu, Jian Zheng, Alise Mendoza, Wei Wen, Lanying Du, Benjamin Spiller, Brian E Wadzinski, Bin Liu, Stanley Perlman, Fang Li
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. Journal of virology (2023)
Yaning Gao, Wanbo Tai, Xinyi Wang, Shibo Jiang, Asim K Debnath, Lanying Du, Shizhong Chen
A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity. BMC biology 20 (1) (2022)
Juan Shi, Gang Wang, Jian Zheng, Abhishek K Verma, Xiaoqing Guan, Moffat M Malisheni, Qibin Geng, Fang Li, Stanley Perlman, Lanying Du
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern. NPJ vaccines 7 (1) (2022)
Juan Shi, Jian Zheng, Wanbo Tai, Abhishek K Verma, Xiujuan Zhang, Qibin Geng, Gang Wang, Xiaoqing Guan, Moffat M Malisheni, Abby E Odle, Wei Zhang, Fang Li, Stanley Perlman, Lanying Du
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection. Journal of virology 96 (17) (2022)
Juan Shi, Gang Wang, Jian Zheng, Abhishek K Verma, Xiaoqing Guan, Moffat M Malisheni, Qibin Geng, Fang Li, Stanley Perlman, Lanying Du
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern. NPJ vaccines 7 (1) (2022)
Lanying Du, Yang Yang, Xiujuan Zhang, Fang Li
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 14 (4) (2022)
Juan Shi, Gang Wang, Jian Zheng, Abhishek K Verma, Xiaoqing Guan, Moffat M Malisheni, Qibin Geng, Fang Li, Stanley Perlman, Lanying Du
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern. NPJ vaccines 7 (1) (2022)
Shibo Jiang, Xiujuan Zhang, Lanying Du
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2. Expert opinion on therapeutic targets 25 (6) (2020)
Shibo Jiang, Lanying Du, Zheng-Li Shi
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerging microbes & infections 9 (1) (2020)
Naru Zhang, Jian Shang, Chaoqun Li, Kehui Zhou, Lanying Du
An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies. Expert review of vaccines 19 (9) (2020)